45 results for "pharmacoresistant epilepsy" · page 1 of 5 · ranked by relevance
…org/10.82901/nemar.on003876) Epilepsy Interictal Dataset ===================== This dataset was updated…
A randomized, placebo-controlled clinical trial investigating the neuroprotective and neuromodulatory effects of intranasal NeuroEPO (erythropoietin) in Parkinson's disease patients. The dataset comprises multisession EEG recordings and clinical assessments collected at two timepoints: baseline (pre-intervention) and 9-month post-intervention, with the goal of examining whether NeuroEPO-related cognitive and motor effects are mediated by changes in EEG source activity and brain function.
…patients with pharmacoresistant epilepsy, recorded at the Sleep-Wake-Epilepsy-Center (SWEC…
A randomized, placebo-controlled clinical trial investigating the neuroprotective and neuromodulatory effects of intranasal NeuroEPO (erythropoietin) in Parkinson's disease patients. The study combines clinical assessments using the MDS-UPDRS III scale with EEG recordings at baseline and 9-month post-intervention timepoints to evaluate whether NeuroEPO-induced changes in brain function, as measured by EEG source activity, mediate cognitive and motor outcomes. This multisession Phase II/III dataset provides evidence for EPO's role in synaptic plasticity and dopaminergic system resilience.
…term iEEG invasively recorded in epilepsy patients implanted with responsive neurostimulation system…
…These data were collected using stereoelectroencephalography recordings of epilepsy patients while they…
…Subjects were epilepsy patients undergoing intracranial monitoring for localization of epileptic seizures…
…surgical treatment for drug resistant epilepsy at the Hospital of the University…
…Participants were included if they had a history of refractory epilepsy and…
…recordings for two patients with epilepsy. The depth electrodes used in this…